6 results about "Efficacy" patented technology

The invention discloses a traditional Chinese medicine preparation for treating the hyperplasia of mammary glands. The traditional Chinese medicine preparation accords with the theory of Chinese herb compatibility, aiming at the fundamental effect, the Indian kalimeris herb, abrus cantoniensis hance, spina gleditsiae, fructus liquidambaris, herba lycopi, musk, alangium leaf, trichosanthes kirilowii Maxim and farfugium japonicum are taken as the monarch drugs for promoting circulation and removing stasis, and dredging breast collaterals; the hemistepta lyrata, the seed of cowherb, felwort, adiantum caudatum, silkworm larva, dandelion and radix rhapontied are taken as the ministerial drugs for reducing swelling and resolving mass, and softening hard mass and stopping pain; the radix curcumae, radix polygonati officinalis, frankincense, rhizoma cyperi, tribulusterrestris, suncured ginseng, cistanche and salvia miltiorrhiza are taken as the adjuvant drugs with coordinating effect, for soothing the liver and regulating vital energy, nourishing the five organs, benefiting the vital essence and reinforcing the functions of the monarch drugs and the ministerial drugs and restraining the toxic side effect of the other medicines. Many medicines are simultaneously used with mild medical effect and permanent effectiveness, so that the functions of promoting qi circulation and stopping pain, removing toxicity and dispersing swelling, calming the liver and dispelling melancholy, and softening hardness to dissipate stagnation can be reached, and the hyperplasia of mammary glands can be cured.

The invention discloses a traditional Chinese medicine preparation for osteoporosis, osteonecrosis, bone generation and blood circulation promotion. The traditional Chinese medicine preparation is prepared from premna fulva Craib, sarcandra twigs and leaves, natural copper, red sage roots, corydalis tubers, twotoothed achyranthes roots and eucommia bark. The invention also provides a preparation method of the traditional Chinese medicine preparation. According to the principle of combining the traditional Chinese medicine theory and the western medicine theory, the traditional Chinese medicinepreparation provided by the invention is scientifically proportioned, and the traditional Chinese medicines are matched with each other to offset weakness, so that traditional Chinese medicine preparation has the effects of promoting blood circulation and removing blood stasis, dredging collaterals and setting bones, relieving swelling and pain, and strengthening tendons and bones, and has obvious effects on treating fracture, osteoporosis and osteonecrosis. Pharmacodynamic and toxicological tests show that the traditional Chinese medicine preparation has obvious effects, has no toxic or sideeffects, and overcomes the defects that western medicines can damage liver and kidney functions and the like after being taken for a long time. The traditional Chinese medicine preparation prepared by using a folk secret prescription of the Zhuang nationality can be prepared into various dosage forms, is convenient and safe to carry and take, and reduces or avoids danger, injury and pain caused by intravenous drip and intramuscular injection treatment. The traditional Chinese medicine preparation has advantages of short treatment course, quick response and wide application range, and has a wide application prospect.

Provided are methods for identifying and treating individuals who have cancer, and also have immunosuppressive neutrophils. The method of treating includes administering one or more drugs that inhibit formation of immunosuppressive neutrophils. Cancer patients can be identified, and selected for treatment, based on a positive result obtained by exposing a biological sample from the patient to normal neutrophils, and subsequently exposing the neutrophils to T cells, and measuring activation of T the cells. Reduced activation of the T cells relative to a control provides an indication that the individual has the immunosuppressive neutrophils, and is a candidate to receive the drug. The drug administered to the cancer patient functions to inhibit SNARE-dependent exocytosis, or inhibits NADPH oxidase, or inhibits complement signaling. The method further includes administering to the individual an immune checkpoint inhibitor, which may increase the efficacy of the checkpoint inhibitor.